[Interleukin-2 and its use in hemo-proliferative disorders].
Interleukin 2 (IL-2) is a cytokine which activates cytotoxic cells and stimulates T suppressor cells and may play a role in the treatment of neoplastic disorders. The majority of clinical trials were performed in renal carcinoma and melanoma. Recent studies showed that IL-2 may also play a role in the treatment of hemoproliferative disorders, but its effectiveness was shown mostly in eradication of minimal residual disease after aggressive chemotherapy and/or bone marrow transplantation.
Hellmann
A
A
Kliniki Hematologii I.Ch.W. Akademii Medycznej w Gdańsku.
D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*
D007376:Interleukin-2
Interleukina-2 i jej zastosowanie w chorobach rozrostowych układu krwiotwórczego.